Totient (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- September 10, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $10,000,000
Company Info
- Founders
- Deniz Kural, PhD
- Company Description
- Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Totient uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates.
- Market
- Healthcare
- Location
- Cambridge, MA, USA